Cart
sales@molnova.com
NEO 376
CAS No. 496921-73-4
NEO 376( SPI-376 )
Catalog No. M26328 CAS No. 496921-73-4
NEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 260 | Get Quote |
|
| 10MG | 417 | Get Quote |
|
| 25MG | 687 | Get Quote |
|
| 50MG | 963 | Get Quote |
|
| 100MG | 1287 | Get Quote |
|
| 500MG | 2601 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNEO 376
-
NoteResearch use only, not for human use.
-
Brief DescriptionNEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.
-
DescriptionNEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.
-
In Vitro——
-
In Vivo——
-
SynonymsSPI-376
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorAlkyl/ether| PEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number496921-73-4
-
Formula Weight357.88
-
Molecular FormulaC20H24ClN3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (349.28 mM)
-
SMILESClc1cccc(c1)N1CCN(CCn2ccc3c2CCCC3=O)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
-
Metoclopramide
A potent dopamine D2 receptor antagonist with Ki of 28 nM; also is a mixed 5-HT3 receptor antagonist/5-HT4 receptor agonist.
-
AMI-193
AMI-193 is an effective and selective antagonist of 5-HT2 and D2 receptor with Kis of 2, 3, 50, 2530, and 4300 nM for 5-HT2, D2 Receptor, 5-HT1A, D1 Receptor, and 5-HT1C Receptor.
-
NGD 94-1
NGD 94-1 is a selective D4 receptor antagonist with an affinity of 3 nM for the D4 receptor and greater than 2 pM for the D1, D2, D3, and D5 receptors.
